4-Chloromethyl-thiazol-2-ylamine hydrochloride, 95.0%, 100g

2-Propenoic acid, 3-(1H-indol-3-yl)-, (2E)-, 95%, 250mg

(R)-3-(1-Aminoethyl)-5-fluorophenol hydrochloride, 95.0%, 250mg

2-[(3,3-DIPHENYLPROPYL)AMINO]ACETAMIDE, 95.0%, 100mg

Diethyl(2-methoxyethyl)methylammonium Bis(fluorosulfonyl)imide>98.0%(N)1g

Sodium 2-(2-amino-3-benzoylphenyl)acetate hydrate, 95.0%, 25g

5-(2,3-Dichlorophenyl)-1,3,4-thiadiazol-2-amine, 97.0%, 5g

2-Bromomethyl-5,7-difluoro-benzo[b]thiophene, 95.0%, 1g

6-Tifluoromethoxy-1H-benzimidazole-2-thiol, 95.0%, 1g

Dibenzo[b,e][1,4]dioxine-2,3,7,8-tetraamine tetrahydrochloride, 97%, 250mg

3-Methyl-1-tosyl-1H-pyrazol-5-amine, 97%, 250mg

4,6-Dichloro-2,5-dimethylpyrimidine, 95.0%, 5g

GC capillary column ROTI®Cap-1701, 30 m, 0.25 mm, 1.00 µm, 1 Piece(s)